Hepatitis C Specialist Doctor in Mumbai Infection with hepatitis C virus ( HCV ) is a major public health worldwide. Approximately 71 million individuals worldwide are chronically infected with HCV, making it one of the world’s most common infectious diseases. The most rapid increase in acute HCV incidence has been found in young adults aged 20 to 39 years old. The percutaneous exposure is the most efficient mode of HCV transmission and injection drug use is the primary risk factor. The other efficient modes of transmission include sharing personal items contaminated with blood, unregulated tattooing, needlestick injuries and perinatal transmission. As it is a largely asymptomatic disease, many patients living with the infection are not aware of their status. It’s chronic infection may progress to more advanced liver conditions, like fibrosis and cirrhosis, cancer of liver and liver failure. There is availability of new direct acting antiviral agents ( DAA ), which has been the most significant advancement in the treatment of hepatitis C. They provide cure rates of more than 95 percent with a treatment duration of 8 to 12 weeks, which has brought an unprecedented opportunity to change the course of the epidemic. The primary barrier that must be overcome to achieve HCV eradication is to increase the detection rate of infected individuals. In fact, a large number of infected patients have not been diagnosed yet. The tests commonly employed for diagnosis are anti – HCV and HCV RNA. Thus it is fundamental to involve a specialist in the diagnosis of a suspected patient of hepatitis C at the earliest. The appropriate evaluation and treatment of individuals chronically infected under guidance of a specialist, will prevent the progression of liver disease and consequently decrease the associated morbidity and mortality.